Bias found when drug manufacturers fund clinical trials
Psychiatric drugs are reported to be about 50% more effective in clinical trials funded by the drug’s manufacturer than when trials of the same drug are sponsored by other groups, new research shows. […] "The addition of unpublished trials reduces the effect of sponsorship, and most of the sponsorship effect can be explained by publication bias," [says the author.]
